We are live on
!
Find out more
SCM
Sio Capital Management Portfolio holdings
AUM
$694M
1-Year Est. Return
79.73%
This Fund
S&P 500
This Quarter
Est. Return
+0.02%
1 Year Est. Return
+79.73%
3 Year Est. Return
+576.62%
5 Year Est. Return
+422.76%
10 Year Est. Return
+2,506.65%
AUM
$694M
AUM Growth
+$90.7M
(+15%)
Cap. Flow
+$121M
Cap. Flow
% of AUM
17.46%
Top 10 Holdings %
Top 10 Hldgs %
45.36%
Holding
89
New
20
Increased
24
Reduced
16
Closed
12
Top Buys
| 1 |
Cencora
COR
|
+$29.7M |
| 2 |
WAY
Waystar Holding Corp
WAY
|
+$27.3M |
| 3 |
Corcept Therapeutics
CORT
|
+$25.2M |
| 4 |
Icon
ICLR
|
+$24.5M |
| 5 |
Maximus
MMS
|
+$21.8M |
Top Sells
| 1 |
Cigna
CI
|
+$47.4M |
| 2 |
Sanofi
SNY
|
+$34.1M |
| 3 |
Celcuity
CELC
|
+$30.9M |
| 4 |
Zimmer Biomet
ZBH
|
+$29.6M |
| 5 |
Kenvue
KVUE
|
+$25.3M |
Sector Composition
| 1 | Healthcare | 92.9% |
| 2 | Industrials | 7.1% |
| 3 | Consumer Staples | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Kymera Therapeutics
KYMR
$9.22B
| $2.68M | 0.39% |
32,235
| – | – |
|
52
Aligos Therapeutics
ALGS
$37.8M
| $2.43M | 0.35% |
327,237
-8,700
| -3% | -$66K |
|
53
Context Therapeutics
CNTX
$57.2M
| $2.4M | 0.35% |
917,922
-423,714
| -32% | -$989K |
|
54
AN2 Therapeutics
ANTX
$171M
| $2.25M | 0.32% |
+657,200
| New | +$1.36M |
|
55
Serina Therapeutics
SER
$31.3M
| $1.94M | 0.28% |
+1,000,000
| New | +$2.2M |
|
56
iBio
IBIO
$71.5M
| $1.72M | 0.25% |
904,268
+164,268
| +22% | +$381K |
|
|
ADGM
57
Adagio Medical Holdings
ADGM
$12.9M
| $1.48M | 0.21% |
1,288,461
| – | – |
|
58
Xilio Therapeutics
XLO
$59.4M
| $1.28M | 0.18% |
152,464
-3
| -0% | -$25 |
|
|
BBOT
59
BridgeBio Oncology
BBOT
$707M
| $1.17M | 0.17% |
130,628
| – | – |
|
60
Hyperfine
HYPR
$103M
| $1.08M | 0.16% |
1,000,000
-1,000,000
| -50% | -$1.14M |
|
61
Senseonics Holdings Inc
SENS
$263M
| $771K | 0.11% |
115,784
| – | – |
|
62
Foghorn Therapeutics
FHTX
$316M
| $587K | 0.08% |
122,889
| – | – |
|
|
TERN
63
DELISTED
Terns Pharmaceuticals
TERN
| $532K | 0.08% |
10,100
| – | – |
|
64
Enanta Pharmaceuticals
ENTA
$381M
| $505K | 0.07% |
40,000
| – | – |
|
65
TELA Bio
TELA
$33.6M
| $395K | 0.06% |
636,300
| – | – |
|
66
NeuroOne Medical Technologies
NMTC
$21.1M
| $386K | 0.06% |
82,769
-107,238
| -56% | -$515K |
|
|
BOLD
67
Boundless Bio
BOLD
$55.3M
| $180K | 0.03% |
163,679
| – | – |
|
|
NYXH
68
Nyxoah
NYXH
$158M
| $148K | 0.02% |
50,839
| – | – |
|
69
Modular Medical
MODD
$23.3M
| $138K | 0.02% |
26,190
-4
| -0% | -$43 |
|
70
Erasca
ERAS
$6.06B
| $80.9K | 0.01% |
+5,000
| New | +$59.1K |
|
71
Rocket Pharmaceuticals Warrant
RCKTW
$310K
| $7.02K | ﹤0.01% |
400,000
| – | – |
|
72
Humacyte Inc Warrant
HUMAW
$1.41M
| $4.57K | ﹤0.01% |
49,998
| – | – |
|
73
Simulations Plus
SLP
$368M
| $2.36K | ﹤0.01% |
+200
| New | +$2.95K |
|
74
Alkermes
ALKS
$8.6B
| – | – |
-95,353
| Closed | -$2.67M |
|
75
Avalo Therapeutics
AVTX
$968M
| – | – |
-72,173
| Closed | -$1.31M |
|
Similar funds
IIC
MCM
CGIC
HA
BBPWM
M
HG
CA